MHRA Authorizes Pfizer, BioNTech COVID-19 Vaccine

December 8, 2020

MHRA Authorizes Pfizer, BioNTech COVID-19 Vaccine

The U.K.'s Medicines & Healthcare Products Regulatory Agency (MHRA) granted a temporary authorization for emergency use to Pfizer and BioNTech for their COVID-19 mRNA vaccine BNT162b2 . This is the first Emergency Use Authorization following a worldwide phase III trial of a vaccine to help fight the pandemic. Like the global population, Yourway has closely followed COVID-19 vaccine trials and is excited about the beginnings of a wider rollout of the vaccine.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

Schedule a Meeting

GCSG 2026 US Conference

April 26-29, 2026
San Diego, CA

Schedule a Meeting

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat

Hello! How can I help you?